相关实验视频

Updated: Jun 20, 2025

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14⁺ Monocytes

Published on: April 11, 2025

重新评估Pidotimod:一种具有30年证据的免疫调节剂

Gian L Marseglia^1,2, Matteo Gelardi³, Pierachille Santus^4,5

¹Clinic of Pediatrics, Foundation IRCCS Polyclinic San Matteo, Pavia, Italy.

|July 17, 2024

概括

皮多蒂莫德是一种合成双,调节先天性和适应性免疫力,以控制感染. 它在预防复发性呼吸道感染和改善各种免疫介导疾病的结果方面表现有前途.

科学领域:

免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

感染引发免疫反应,但免疫力受损或持续的炎症可能会使结果变得更糟.
调节免疫功能提供了一种治疗策略来控制感染.
皮多蒂莫德是一种合成二,具有已证明的免疫调节特性.

研究的目的:

审查Pidotimod的多方面的作用机制.
总结关于Pidotimod在各种免疫介导疾病中的疗效的证据.
探索Pidotimod在治疗呼吸道感染和其他免疫疾病方面的潜力.

主要方法:

综述了30年来积累的大量科学文献.
对Pidotimod对代谢概况,临床结果和免疫学参数的影响的研究分析.
检查Pidotimod在COVID-19和疫苗接种中的作用的初步数据.

主要成果:

皮多蒂莫德调节了先天性和适应性免疫.
有证据支持Pidotimod可以预防复发性呼吸道感染和慢性支气管炎恶化.
最近的研究表明,Pidotimod对支气管炎,肺炎,过敏性鼻炎,喘和艾滋病毒的影响,在COVID-19和疫苗不良事件中可能有好处.

结论:

皮多蒂莫德的免疫调节特性使其成为呼吸道感染的有价值选择.
它显示出治疗其他免疫媒介疾病的潜力,如过敏,COPD和喘.
进一步的研究支持Pidotimod作为免疫系统调节的治疗剂.

更多相关视频

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes

Published on: June 22, 2016

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...